Skip to content

A randomized, controlled, investigator initiated clinical trial testing the efficacy of Indirect acupuncture therapy performed at the abdominal and lower extremity acupuncture points on diarrhea-type irritable bowel syndrome

A randomized, controlled, investigator initiated clinical trial testing the efficacy of Indirect acupuncture therapy performed at the abdominal and lower extremity acupuncture points on diarrhea-type irritable bowel syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0010836
Enrollment
36
Registered
2025-08-01
Start date
2024-10-21
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : acupuncture as an korean medical device Experimental group 1 : standard treatment + acupuncture treatment was performed for 20 minutes in 4 acupoints on abdomen Experimental group 2

Sponsors

Dongshin University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) 20 years of age or older among patients with irritable bowel syndrome who satisfy Rome IV a person under 75 years of age ; Patients falling under ? and ?, including at least two of ? ? ? If abdominal pain and abdominal discomfort persist for more than two days a month in the last three months ? If abdominal pain has been repeated for more than one day a week in the last three months ? If you have discomfort related to defecation ? If there is a change in the frequency of feces (increasing or decreasing) ? If there is a change in the shape of the stool (appearance) ? Symptoms started at least six months ago, and if it falls under ? or ? 2) Those whose weekly average of the most severe abdominal pain in the last 7 days is 3 or higher on a scale of 0 to 10 3) A person who has experienced at least one type 6 or 7 diarrhea-type stool according to the Bristol Stool Form Scale/BSFS2) in the last 7 days for at least 2 days 4) A person who does not have a matrix lesion in the large intestine in barium colonography or colonoscopy performed within the last 5 years 5) A person who has consented in writing to this clinical trial and is deemed competent to conduct this study

Exclusion criteria

Exclusion criteria: 1) Patients who have undergone gastrointestinal surgery (except appendectomy and hernia surgery) 2) If a disease (e.g., an organic disease such as colitis or colorectal cancer) is present or has been within the past two years that may affect the evaluation of the effectiveness of digestive system drugs 3) an antithrombotic/blood coagulant 4) a cardiovascular patient 5) Serious internal medical conditions (e.g., liver cancer or cirrhosis, chronic renal failure, heart failure, thyroid disease) are accompanied 6) Pregnant and lactating women or women of childbearing age who do not use appropriate contraception 7) A person who participated in a clinical study related to acupuncture within the last 6 months 8) A person with skin allergies or skin ulcers or skin infections related to saliva 9) Other patients found difficult to participate in this clinical trial by the tester

Design outcomes

Primary

MeasureTime frame
Irritable Bowl Syndrome-Symptom Severity Scale

Secondary

MeasureTime frame
Bristol stool scale;EQ-5D-5L;Patient Global Assessment;collection of human-derived materials

Countries

Korea, Republic of

Contacts

Public ContactJaeuk Sul

Dongshin University

sjuomd@hanmail.net+82-62-350-7114

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026